NCT05472428

Outcomes of Autologous Bone Marrow Mononuclear Cell Administration in the Treatment of Neurologic Sequelea in Children With Spina Bifida

Autologous Bone Marrow Mononuclear Cell Administration in the Treatment of Neurologic Sequela in Children With Spina Bifida

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 11 (actual)
• Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology · Academic / Other
• Sex: All
• Age: 6 Months – 15 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study was to evaluate the safety and efficacy of autologous bone marrow mononuclear cell infusion in the management of neurological sequelae in children with spina bifida

Detailed description

The aim of this study was to evaluate the safety and effectiveness of autologous bone marrow mononuclear cells in 11 patients with spina bifida at Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam from 2016 to 2020

Conditions

• Stem Cell Infusion

Interventions

Type	Name	Description
COMBINATION_PRODUCT	Autologous bone marrow mononuclear cell transplantation	Transplantation of Autologous Bone Marrow Mononuclear cells

Timeline

• Start date: 2016-07-01
• Primary completion: 2020-12-25
• Completion: 2021-08-31
• First posted: 2022-07-25
• Last updated: 2022-07-25

Locations

1 site across 1 country: Vietnam